Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
62 Results Found
HRSA extends deadline to April 20 for comments on 340B rebate model RFI and suggests expanded number of drugs to be included
The Health Resources and Services Administration Feb.
AHA 340B Advocacy Alliance Bulletin - February 25, 2026
The Health Resources and Services Administration today said it will extend the deadline to April 20 to receive comments.
Use Revised AHA Model Letter to Submit Comments on 340B Rebate Model RFI by New April 20 Deadline
HRSA has extended comment deadline and suggested a significantly expanded scope of rebate program.
AHA House E&C Testimony on Lowering Health Care Costs for All Americans: An Examination of the U.S. Provider Landscape
AHA President and CEO Rick Pollack testimony before the House Committee on Energy and Commerce Subcommittee on Health on Lowering Health Care Costs for All Americans: An Examination of the U.S. Provider Landscape.
AHA 340B Advocacy Alliance Bulletin - February 19, 2026
The American Hospital Association 340B Advocacy Alliance Bulletin for February 19, 2026.
AHA Comments on CMS Proposed GLOBE Model
While the AHA broadly supports the Administration’s objectives as described in the proposed rule, we believe the GLOBE Model as proposed lacks critical operational details that, if not properly clarified, could create additional burden for hospitals and health systems.
AHA Urges HRSA to Stop Eli Lilly’s New Policy on 340B Hospitals From Going into Effect
The American Hospital Association (AHA) expresses serious concerns with the recent announcement by Eli Lilly and Company (Lilly) to require 340B covered entities to submit claims data for all dispensations of all Lilly drugs, regardless of setting.
340B is a Solution, not a Threat to Addressing Health Care Affordability in the U.S.
Many Americans may be unaware that the services they rely on every day through their local hospital are supported by a program called the 340B Drug Pricing Program.
Central Vermont Medical Center | Vermont
Central Vermont Medical Center (CVMC) erves a population of 66,000 and employs nearly 1,400 people in one of the most rural regions of the country. The not-for-profit community health care provider treats more than 25,000 patients through its Emergency Department, provides care to over 164,000 Vermonters in its 27 outpatient facilities, and performs over 3,000 outpatient surgeries annually.